166 related articles for article (PubMed ID: 15713474)
1. Structural characterization of the cell wall binding domains of Clostridium difficile toxins A and B; evidence that Ca2+ plays a role in toxin A cell surface association.
Demarest SJ; Salbato J; Elia M; Zhong J; Morrow T; Holland T; Kline K; Woodnutt G; Kimmel BE; Hansen G
J Mol Biol; 2005 Mar; 346(5):1197-206. PubMed ID: 15713474
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate recognition by Clostridium difficile toxin A.
Greco A; Ho JG; Lin SJ; Palcic MM; Rupnik M; Ng KK
Nat Struct Mol Biol; 2006 May; 13(5):460-1. PubMed ID: 16622409
[TBL] [Abstract][Full Text] [Related]
3. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters.
Geric B; Carman RJ; Rupnik M; Genheimer CW; Sambol SP; Lyerly DM; Gerding DN; Johnson S
J Infect Dis; 2006 Apr; 193(8):1143-50. PubMed ID: 16544255
[TBL] [Abstract][Full Text] [Related]
4. [PCR cloning of 3'-terminal repeat fragments of Clostridium difficile toxin A and toxin B gene].
Yang XQ; Jiang B; Sun Y; Wang JD
Di Yi Jun Yi Da Xue Xue Bao; 2002 Sep; 22(9):791-3. PubMed ID: 12297432
[TBL] [Abstract][Full Text] [Related]
5. Comparison of wild type with recombinant Clostridium difficile toxin A.
Gerhard R; Burger S; Tatge H; Genth H; Just I; Hofmann F
Microb Pathog; 2005; 38(2-3):77-83. PubMed ID: 15748809
[TBL] [Abstract][Full Text] [Related]
6. The enzymatic domain of Clostridium difficile toxin A is located within its N-terminal region.
Faust C; Ye B; Song KP
Biochem Biophys Res Commun; 1998 Oct; 251(1):100-5. PubMed ID: 9790914
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile toxin: cytoskeletal changes and lactate dehydrogenase release in hepatocytes.
Grossmann EM; Longo WE; Kaminski DL; Smith GS; Murphy CE; Durham RL; Shapiro MJ; Norman JG; Mazuski JE
J Surg Res; 2000 Feb; 88(2):165-72. PubMed ID: 10644484
[TBL] [Abstract][Full Text] [Related]
8. Clostridium perfringens iota-toxin: mapping of receptor binding and Ia docking domains on Ib.
Marvaud JC; Smith T; Hale ML; Popoff MR; Smith LA; Stiles BG
Infect Immun; 2001 Apr; 69(4):2435-41. PubMed ID: 11254604
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol, it's not just for heart disease anymore.
Kerzmann A; Feig AL
ACS Chem Biol; 2006 Apr; 1(3):141-4. PubMed ID: 17163660
[TBL] [Abstract][Full Text] [Related]
10. Bacillus sphaericus mosquitocidal toxin (MTX) and pierisin: the enigmatic offspring from the family of ADP-ribosyltransferases.
Carpusca I; Jank T; Aktories K
Mol Microbiol; 2006 Nov; 62(3):621-30. PubMed ID: 17076664
[TBL] [Abstract][Full Text] [Related]
11. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1.
Buonpane RA; Moza B; Sundberg EJ; Kranz DM
J Mol Biol; 2005 Oct; 353(2):308-21. PubMed ID: 16171815
[TBL] [Abstract][Full Text] [Related]
12. Mutagenesis of the Clostridium difficile toxin B gene and effect on cytotoxic activity.
Barroso LA; Moncrief JS; Lyerly DM; Wilkins TD
Microb Pathog; 1994 Apr; 16(4):297-303. PubMed ID: 7968458
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of C. difficile.
Martinez RD; Wilkins TD
J Med Microbiol; 1992 Jan; 36(1):30-6. PubMed ID: 1370542
[TBL] [Abstract][Full Text] [Related]
14. Toxin A-negative, toxin B-positive Clostridium difficile.
Drudy D; Fanning S; Kyne L
Int J Infect Dis; 2007 Jan; 11(1):5-10. PubMed ID: 16857405
[TBL] [Abstract][Full Text] [Related]
15. Lack of value of repeat stool testing for Clostridium difficile toxin.
Mohan SS; McDermott BP; Parchuri S; Cunha BA
Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a modular structure of the homologous repetitive C-terminal carbohydrate-binding sites of Clostridium difficile toxins and Streptococcus mutans glucosyltransferases.
von Eichel-Streiber C; Sauerborn M; Kuramitsu HK
J Bacteriol; 1992 Oct; 174(20):6707-10. PubMed ID: 1307487
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of the calcium-binding C-terminal domain of Clostridium perfringens alpha-toxin.
Naylor CE; Jepson M; Crane DT; Titball RW; Miller J; Basak AK; Bolgiano B
J Mol Biol; 1999 Dec; 294(3):757-70. PubMed ID: 10610794
[TBL] [Abstract][Full Text] [Related]
18. Structure of the key toxin in gas gangrene.
Naylor CE; Eaton JT; Howells A; Justin N; Moss DS; Titball RW; Basak AK
Nat Struct Biol; 1998 Aug; 5(8):738-46. PubMed ID: 9699639
[TBL] [Abstract][Full Text] [Related]
19. Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells.
Chaves-Olarte E; Weidmann M; Eichel-Streiber C; Thelestam M
J Clin Invest; 1997 Oct; 100(7):1734-41. PubMed ID: 9312171
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A.
Ho JG; Greco A; Rupnik M; Ng KK
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18373-8. PubMed ID: 16344467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
